Faeth Therapeutics (FTH) Change in Cash (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Change in Cash came in at $143.7 million in Q1 2026, up 122883.76% YoY from N/an in Q1 2025, and up 7684.85% on a QoQ basis from -$1.9 million in Q4 2025.
Faeth Therapeutics (FTH) Change in Cash (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Change in Cash data on file, last reported at $143.7 million in Q1 2026.
- Quarterly Change in Cash rose 122883.76% year-over-year to $143.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.4 million (up 13301.85% YoY) and the FY2025 annual result came in at -$1.3 million, up 56.05% from the prior year.
- Change in Cash grew to $143.7 million in Q1 2026, from -$1.9 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $143.7 million in Q1 2026 to a low of -$9.7 million in Q1 2023.
- A 5-year average of $8.5 million and a median of $1.2 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 720.1% — and 2026, when it soared 122883.76%.
- Tracing FTH's Change in Cash over 5 years: stood at $6.3 million in 2022, then tumbled by 73.71% to $1.7 million in 2023, then sank by 647.78% to -$9.1 million in 2024, then jumped by 79.27% to -$1.9 million in 2025, then surged by 7684.85% to $143.7 million in 2026.
- The last three Change in Cash figures came in at $143.7 million (Q1 2026), -$1.9 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - | -125.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -125.42 Mn |
| Mar 31, 2026 | 143.66 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | -117,000.00 |
| Dec 31, 2024 | -9.14 Mn |
| Sep 30, 2024 | 7.24 Mn |
| Jun 30, 2024 | 935,000.00 |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | -9.69 Mn |
| Dec 31, 2022 | 6.35 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | -2.37 Mn |
| Sep 30, 2021 | -6.07 Mn |